Mutant EGFR inhibitor |
| Katalog-Nr.GC11126 |
Mutanter EGFR-Inhibitor ist ein potenter und selektiver mutanter EGFR-Inhibitor, extrahiert aus dem Patent WO 2013014448 A1; hemmt EGFRL858R, EGFRExon 19-Deletion und EGFRT790M.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1421373-62-7
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor(L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant).
Review for Mutant EGFR inhibitor
Average Rating: 5 (Based on Reviews and 24 reference(s) in Google Scholar.)
Review for Mutant EGFR inhibitor
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *